State/UT wise details of total operational COVID-19 testing laboratories (as on 20th September, 2020)
|S. No.||State/UT||No. of laboratories|
|1||Andaman and Nicobar Islands||5|
|8||Dadra and Nagar Haveli||1|
|14||Jammu and Kashmir||27|
As per information maintained by ICMR, laboratories in the following medical colleges of Chhattisgarh are conducting COVID-19 testing by RT-PCR:
- All India Institute of Medical Sciences, Raipur
- Late Baliram Kashyap M Govt. Medical College, Jagdalpur
- JNM Medical College, Raipur
- Late Shri Lakhi Ram Agrawal Memorial Govt. Medical College, Raigarh
- Government Medical College and Hospital, Ambikapur
- Chhattisgarh Institute of Medical Sciences, Bilaspur
- Bharat Ratna Late Shri Atal Bihari Vajpayee Memorial Medical College, Pendri, Rajnandgaon
- Raipur Institute of Medical Sciences, 4th Floor, College Building, Rims Knowledge Park, Raipur
Government of India has taken a series of actions to prevent, control and mitigate the impact of COVID-19. India followed a whole of Government and whole of society approach. Hon’ble Prime Minister, a High level Group of Ministers (GoM), Cabinet Secretary, Committee of Secretaries and senior officers in MoHFW continue to monitor public health response to COVID-19 in the country.
The public health actions were taken in a pre-emptive, pro-active, graded manner based on the evolving scenario. A number of travel advisories were issued restricting inflow of international travelers, till such time, commercial flights were suspended on 23rd March, 2020. Till then, a total of 14,154 flights with 15,24,266 passengers have been screened at these airports. Screening was also done at 12 major and 65 minor ports and land border crossings. In the initial part of the pandemic, India evacuated a large number of stranded passengers from then COVID affected countries (China, Italy, Iran, Japan, Malaysia) and again in the un-lockdown phase, a total of 13,76,090 passengers have been brought back (as reported on 20th September, 2020) and followed up.
Integrated Disease Surveillance Programme (IDSP) is conducting contact tracing through community surveillance. In the earlier part of the pandemic, this was done for travel related cases and subsequently for cases being reported from community as a part of containment strategy. As on 20th September 2020, a total of about 40 lakh persons have been kept under surveillance. India is testing is about 1 million samples a day. A total of 6.43 crore samples have been tested so far (as on 20th September 2020).
As on 21st September, 2020, a total of 15,373 COVID treatment facilities with 13,18,826 dedicated isolation bed without O2 support have been created. Also, a total of 2,35,901 oxygen supported isolation beds and 64,868 ICU beds (including 32,792 ventilator beds).Guidelines on Clinical management of COVID-19 have been issued and are being updated regularly.
States are being supported in terms of supply of logistics. So far 1.42 Crore of PPE Kits, 3.45 crores N-95 masks, 10.84 crore tablets of Hydroxychloroquine, 30,841 ventilators and 1,02,400 oxygen cylinders have been supplied to States/UTs/ Central Government hospitals so far (as reported on 20th September, 2020).
Various cadres of personnel and volunteers across sectors and departments for COVID related worksand maintenance of other essential medical services have been worked out, trained throughresources made available on the website of MoHFW, iGOT (online platform) by DOPT (https://igot.gov.in/igot/).
MoHFW website is being daily to provide general public with information on current status of COVID-19 spread in India. Communication material is also being hosted on MoHFW website and through social media. A dedicated call centre / helpline (1075) has been started to guide community at large which are being used by the citizens very effectively and on a regular basis.
More than 30 vaccine candidates have been supported which are in different stages of development, 3 candidates are in advanced stage of Phase I/II/III trials and more than 4 are in advanced pre-clinical development stage. A National Expert Group on Vaccine Administration for COVID-19 has been constituted on 7th August, 2020, under NITI Ayog. Thirteen clinical trials of repurposed drugs have been undertaken to build a portfolio of therapeutic options for Covid-19 patients.
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Lok Sabha here today.